A study in BMC Immunology identified miR-379-5p as a biomarker associated with sepsis-associated acute kidney injury and patient outcomes. Investigators reported that low miR-379-5p expression tracked disease severity and was linked to mortality at 28 days. The work builds biomarker evidence in a high-need space: early identification of which sepsis patients will develop acute kidney injury can guide monitoring intensity and therapeutic decisions. Here, the biomarker relationship spans both severity stratification and survival. From a translational perspective, microRNA markers may offer earlier detection compared with some conventional clinical chemistry metrics, although further validation in independent cohorts and across care settings will be critical. If replicated, miR-379-5p could become a candidate for diagnostic panels or risk models for sepsis kidney injury.